Maria Pilar Miralles Exposito
Grado: Máster
Publicaciones
-
Torres, P; Rico-Rios, S; Ceron-Codorniu, M; Santacreu-Vilaseca, M; Seoane-Miraz, D; Jad, Y; Ayala, V; Mariño, G; Beltran, M; Miralles, MP; Andrés-Benito, P; Fernandez-Irigoyen, J; Santamaria, E; López-Otín, C; Soler, RM; Povedano, M; Ferrer, I; Pamplona, R; Wood, MJA; Varela, MA; Portero-Otin, M
TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition
ACTA NEUROPATHOLOGICA 148 45-45. .
-
Ceron-Codorniu, M; Torres, P; Fernández-Bernal, A; Rico-Rios, S; Serrano, JCE; Miralles, MP; Beltran, M; Garcera, A; Soler, RM; Pamplona, R; Portero-Otín, M
TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells
Redox Biology 75 103301-103301. .
-
Sansa, A; Miralles, MP; Beltran, M; Celma-Nos, F; Caldero, J; Garcera, A; Soler, RM
ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in Spinal Muscular Atrophy motoneurons.
Cell Death Discovery 9 113-113. .
-
Miralles MP; Sansa A; Beltran M; Soler RM; Garcera A
Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons.
FRONTIERS IN CELLULAR NEUROSCIENCE 16 1054270-1054270. .
Proyectos
- Ajuts al Talent en Investigació Biomèdica 2024 - 12a Edició
- Ajuts contractació personal investigador predoctoral en formació (FI2022)
- Analysis of the beneficial effects of calpain inhibitors treatment and combined therapies on Spinal Muscular Atrophy
- Nuevas terapias para el tratamiento de la Atrofia Muscular Espinal: inhibidores de la calpaina y células madre mesenquimales modificadas
